Clinical Trials Sponsored by Anokion SA

Total 1029 results

Rhizen Pharmaceuticals SA

Terminated

Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas

Lymphoma

United States, Australia
Regen Lab SA

Completed

Treatment of Keloid Scar by Autologous Platelet Rich Plasma Obtained With RgenKit-BCT

Keloid
Regen Lab SA

Unknown

Cellular Matrix Device for the Treatment of Mild to Moderate Knee Osteoarthritis

Knee Osteoarthritis

France
Debiopharm International SA

Completed

Study of Debio 1450 for Bacterial Skin Infections

Bacterial Infections

United States
Celyad Oncology SA

Withdrawn

EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2 (EPITHINK)

Myelodysplastic Syndromes | AML, Adult
Biosensors Europe SA

Completed

e-BioMatrix Canada Registry

Device Related MACE and Bleeding

Canada
Biosensors Europe SA

Completed

e-BioMatrix PostMarket Registry (eBMX-PMR)

Coronary Artery Disease

United Kingdom, Spain, France, Ireland, Switzerland, Germany, Denmark, Austria, Latvia, Czechia, Jordan, Lithuania, Morocco, Poland, Portugal, Russian Federation
Biosensors Europe SA

Completed

e-BioMatrix PostMarket Surveillance Registry

Coronary Artery Disease

Switzerland, Spain, United Kingdom
Miracor Medical SA

Completed

PiCSO in ACS Study

Acute Coronary Syndrome

United Kingdom
Medacta International SA

Unknown

Understanding GMK Sphere Implant Tibiofemoral Kinematics by Means of Dynamic Videofluoroscopy

Arthroplasty | Replacement, Knee

Switzerland
Helsinn Healthcare SA

Terminated

Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients

Breast Cancer | Lung Cancer | Colon Cancer

Italy
Rhizen Pharmaceuticals SA

Completed

To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers

Healthy

Canada
MedDay Pharmaceuticals SA

Completed

MD1003-AMN MD1003 in Adrenomyeloneuropathy

Adrenoleukodystrophy | Adrenomyeloneuropathy | AMN

France, Germany, Spain
Helsinn Healthcare SA

Completed

Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA (MEI-005)

Myelodysplastic Syndrome | MDS

United States
Debiopharm International SA

Terminated

Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1

Hepatitis C

United States
Quantum Genomics SA

Completed

Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension (2QG1)

Essential Hypertension

France
Helsinn Healthcare SA

Withdrawn

Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer

Cancer Patients With Cachexia

Australia
Debiopharm International SA

Completed

Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants

Chronic Pain | Hepatitis C

United States, Belgium, Germany, Taiwan, Australia, France, Thailand, Puerto Rico, United Kingdom, Italy, India, Poland, Korea, Republic of, Canada
Celyad Oncology SA

Unknown

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL (CHART-2)

Heart Failure
Debiopharm International SA

Completed

Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients

Hepatitis C | Liver Disease

Germany, Sweden, United Kingdom, Poland
Rheon Medical SA

Unknown

Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device

Glaucoma

Switzerland
Debiopharm International SA

Completed

A Single Dose Study of Debio 1450 in Healthy Subjects

Bacterial Infections

United States
Air Liquide SA

Terminated

General Anesthesia With Xenon in Inspiratory Concentrations of 50% and 70% and Total I.V. Anaesthesia.

Anaesthesia

United Kingdom, France, Germany
Miracor Medical SA

Completed

PICSO in Patients With STEMI Treated by Primary Percutaneous Coronary Intervention (pRAMSES)

ST Elevation (STEMI) Myocardial Infarction

Netherlands
Helsinn Healthcare SA

Completed

Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea

Diarrhea

Russian Federation, Bulgaria, Hungary, Romania
Cerenis Therapeutics, SA

Completed

Exploratory Study of Plaque Regression (EXPRESS)

Heterozygous Familial Hypercholesterolemia

Canada
Air Liquide SA

Completed

NOWOX Oxygen Therapy Monitoring Device

Chronic Obstructive Pulmonary Disease

France
Fovea Pharmaceuticals SA

Completed

Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Fovea Pharmaceuticals SA

Terminated

Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion (FOV2302)

Central Retinal Vein Occlusion | Macular Edema

France
SeneXta Therapeutics SA

Completed

Safety and Pharmacokinetics of SNX-001 in Healthy Aged Volunteers

Safety

Germany
University of Crete
Galenica SA; Olvos Science SA

Completed

Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients (COVID-19-IAMA)

Covid19 | Respiratory Viral Infection | Viral Infection

Greece
Ryvu Therapeutics SA

Not yet recruiting

RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis (POTAMI-61)

Myelofibrosis

Italy, Poland
ABSCINT NV/SA

Not yet recruiting

HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011 (HERMIA)

Metastatic Breast Cancer

Belgium
Ryvu Therapeutics SA

Recruiting

Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML

Acute Myeloid Leukemia

Italy, Poland
Technophage, SA
VectorB2B

Recruiting

Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection (REVERSE2)

Diabetic Foot Infection

United States, India
Medacta International SA

Recruiting

Clinical Utility and Gait Analysis of NextAR System AUS

Total Knee Arthroplasty

Australia
Bio Sidus SA

Recruiting

Switch Over Study of Biosimilar AGA for Fabry Disease (SMILE)

Fabry Disease

Argentina
Medacta International SA

Recruiting

MySpine MC Versus MySpine Standard (MC vs STD)

Degenerative Disc Disease | Osteochondrosis | Spondylolysis Lumbar

Switzerland
Medacta International SA

Recruiting

A Safety Study on Posterior Pedicle Screw System (MUST MINI PMS)

Degenerative Disc Disease | Trauma Injury | Tumor

Germany
Biosensors Europe SA

Recruiting

ULTRA LONG: BioFreedom Ultra

Coronary Artery Disease | High Bleeding Risk Patients

United Kingdom
Arga Medtech SA

Recruiting

Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation (BURST-AF)

Atrial Fibrillation

Georgia
Medacta International SA

Recruiting

The Medacta GMK SpheriKA Post-Marketing Surveillance Study

Arthropathy | Knee Replacement

France, Italy, Switzerland
Ichnos Sciences SA

Recruiting

Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

United States, Australia
Medacta International SA

Recruiting

Mirror Medacta Shoulder System Pivotal Trial

Arthritis Shoulder | Post-traumatic Arthrosis of Other Joints, Upper Arm

Switzerland
Medacta International SA

Recruiting

The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study

Arthritis | Rheumatoid Arthritis | Avascular Necrosis | Traumatic Arthritis | Poly-arthritis

France, Switzerland
Medacta International SA

Recruiting

Mpact 3D Metal Cup PMS

Total Hip Arthroplasty

Italy
Rhizen Pharmaceuticals SA

Completed

Compassionate Use Study of Tenalisib (RP6530)

Hematological Malignancies

United States, Georgia, Poland
Rhizen Pharmaceuticals SA

Completed

Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

Solid Tumor | Metastatic Breast Cancer | Locally Advanced Breast Cancer | Extensive-stage Small-cell Lung Cancer | Platinum-Sensitive Fallopian Tube Carcinoma | Platinum-sensitive Ovarian Cancer | Platinum-Sensitive Peritoneal Cancer

Czechia, Poland
Medacta International SA

Active, not recruiting

GMK-UNI Anatomical UKA: Fixation of Cemented vs Cementless Designs

Osteoarthritis, Knee

France, Switzerland
AB Biotics, SA

Completed

Prospective Study to Determine the Factors Influencing Infant Colic

Infant Colic

Mexico, Spain

Clinical Trials Sponsored by Anokion SA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations